Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | HTT | P42858 | 5/20 | 0.58 |
| ▸ | HPGD | P15428 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | ATM | Q13315 | 2/20 | 0.50 |
| ▸ | EDNRA | P25101 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17691641 | 0.94 | KDM4E (0.53) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL28988538 | 0.93 | MAPT (0.68) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL30352484 | 0.93 | MAPT (0.68) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL16171511 | 0.91 | MAPT (0.50) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL29539968 | 0.91 | MAPT (0.62) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL29415 | 0.91 | MAPT (0.62) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL15435752 | 0.90 | MAPT (0.55) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL12628264 | 0.90 | MAPT (0.55) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL12628267 | 0.90 | MAPT (0.55) | MAPTHTTHPGDKDM4EALDH1A1 | |
| SCHEMBL15074751 | 0.90 | MAPT (0.54) | MAPTHTTHPGDKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022257817-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS | 清华大学 | 2022-12-15 | — | — | WO | disclosed |
| US-10644243-B2 | N-phenyl triscarbazole | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-20190259964-A1 | ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM | SOLVAY SA (BE) | 2019-08-22 | — | — | US | disclosed |
| WO-2017216168-A1 | ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM | SOLVAY SA (BE) | 2017-12-21 | — | — | WO | disclosed |
| EP-3257849-A1 | ORGANIC SEMICONDUCTOR COMPOSITION AND SEMICONDUCTING LAYER OBTAINED THEREFROM | Solvay SA (BE) | 2017-12-20 | — | — | EP | disclosed |
| EP-2609080-B1 | N-PHENYL TRISCARBAZOLE | SOLVAY (BE) | 2016-03-30 | — | — | EP | disclosed |
| EP-2609080-B1 | N-PHENYL TRISCARBAZOLE | SOLVAY (BE) | 2016-03-30 | — | — | EP | disclosed |
| EP-2609080-A1 | N-PHENYL TRISCARBAZOLE | Solvay SA (BE) | 2013-07-03 | — | — | EP | disclosed |
| EP-2433928-A1 | N-phenyl triscarbazole | Solvay SA (BE) | 2012-03-28 | — | — | EP | disclosed |
| EP-2433928-A1 | N-phenyl triscarbazole | Solvay SA (BE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2012025510-A1 | N-PHENYL TRISCARBAZOLE | SOLVAY SA (BE) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012025510-A1 | N-PHENYL TRISCARBAZOLE | SOLVAY SA (BE) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10644243-B2 | N-phenyl triscarbazole | RB1, LBR, NR1I2 | MAPT 3361/4885HTT 933/4885HPGD 1980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.